~~<i id='94639E78FD'><strike id='94639E78FD'><tt id='94639E78FD'><pre id='94639E78FD'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

author：hotspot 2025-09-05 18:33:00 - browse：23418

For a decade, leading academic institutes and their associated companies fought a bruising, headline-grabbing fight over who held patent rights to CRISPR-Cas9, the revolutionary genome editing tool.

Editas Medicine, the winner of that battle in the U.S., will now cash in.

Vertex Pharmaceuticals and Editas announced Wednesday that Vertex will pay Editas $50 million, along with a series of annual payments through 2034, in exchange for rights to use CRISPR-Cas9 in Casgevy, the sickle cell therapy approved last week.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Q&A: Jennifer Adair on making gene therapy available globally

hotspot

Wikipedia

entertainment

Wikipedia

hotspot

explore

AlexHogan/STATGeneticevidenceoftheH5N1birdfluviruswas found ingrocerystoremilkintheUnitedStatesthisw

WSS

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

MultiPlan and major insurers sued for alleged medical price

UpToDate has a racism problem: Dr. Stanley Goldfarb

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Exact Sciences stock tumbles despite strong cancer detection sales

Q&A: Jennifer Adair on making gene therapy available globally

entertainment

entertainment

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

What affirmative action's end means to a medical student

Peter Hotez and the public health issue of online harassment

Crowdfunding for unproven stem cell procedures spreads misinformation

Wildfire smoke exposes gaps in outdoor worker protections

AstraZeneca lung cancer study comes in below expectations

Duchenne breakthrough therapy leaves behind pioneering families

What affirmative action's end means to a medical student

Apple is now the first public company to be valued at $3 trillion

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Wikipedia

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

AstraZeneca lung cancer study comes in below expectations

Canadians with cystic fibrosis outlive Americans by a decade

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

What affirmative action's end means to a medical student

After traumatic brain injury, life support decisions can use more time

entertainment

Wikipedia

hotspot

explore